| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 348 | 2024 | 3047 | 24.040 |
Why?
|
| Pulmonary Emphysema | 81 | 2024 | 672 | 8.070 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 33 | 2022 | 107 | 5.080 |
Why?
|
| Forced Expiratory Volume | 119 | 2024 | 1745 | 4.660 |
Why?
|
| Emphysema | 26 | 2024 | 247 | 4.510 |
Why?
|
| Genetic Predisposition to Disease | 165 | 2023 | 17445 | 4.260 |
Why?
|
| Lung | 133 | 2024 | 9857 | 4.080 |
Why?
|
| alpha 1-Antitrypsin | 24 | 2022 | 163 | 3.840 |
Why?
|
| Smoking | 152 | 2023 | 8987 | 3.720 |
Why?
|
| Genome-Wide Association Study | 137 | 2024 | 12262 | 3.590 |
Why?
|
| Polymorphism, Single Nucleotide | 145 | 2023 | 15520 | 3.450 |
Why?
|
| Spirometry | 66 | 2024 | 865 | 2.930 |
Why?
|
| Asthma | 81 | 2023 | 6010 | 1.990 |
Why?
|
| Genetic Loci | 24 | 2023 | 2575 | 1.910 |
Why?
|
| Genetic Linkage | 27 | 2019 | 2421 | 1.860 |
Why?
|
| Vital Capacity | 40 | 2024 | 925 | 1.780 |
Why?
|
| Phenotype | 123 | 2023 | 16367 | 1.770 |
Why?
|
| Respiratory Function Tests | 52 | 2023 | 1617 | 1.680 |
Why?
|
| GTPase-Activating Proteins | 10 | 2021 | 498 | 1.680 |
Why?
|
| Transforming Growth Factor beta2 | 3 | 2021 | 75 | 1.600 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 12 | 2023 | 451 | 1.530 |
Why?
|
| Lung Diseases, Interstitial | 13 | 2023 | 808 | 1.500 |
Why?
|
| Tomography, X-Ray Computed | 95 | 2024 | 20130 | 1.460 |
Why?
|
| Bronchitis, Chronic | 10 | 2022 | 62 | 1.310 |
Why?
|
| Genotype | 81 | 2023 | 12952 | 1.280 |
Why?
|
| Receptors, Nicotinic | 8 | 2019 | 497 | 1.220 |
Why?
|
| Iron Regulatory Protein 2 | 8 | 2016 | 41 | 1.210 |
Why?
|
| Bronchodilator Agents | 19 | 2022 | 502 | 1.200 |
Why?
|
| Humans | 578 | 2024 | 744376 | 1.150 |
Why?
|
| Disease Progression | 45 | 2023 | 13285 | 1.140 |
Why?
|
| Middle Aged | 293 | 2024 | 213388 | 1.120 |
Why?
|
| Genome, Human | 27 | 2023 | 4420 | 1.100 |
Why?
|
| Epoxide Hydrolases | 6 | 2010 | 122 | 1.090 |
Why?
|
| Models, Genetic | 29 | 2022 | 3493 | 1.070 |
Why?
|
| Polymorphism, Genetic | 29 | 2017 | 4328 | 1.030 |
Why?
|
| Lung Diseases, Obstructive | 11 | 2008 | 316 | 1.030 |
Why?
|
| Case-Control Studies | 76 | 2023 | 21747 | 1.020 |
Why?
|
| Severity of Illness Index | 74 | 2022 | 15535 | 1.020 |
Why?
|
| Male | 356 | 2024 | 350118 | 0.990 |
Why?
|
| Aged | 227 | 2023 | 163284 | 0.960 |
Why?
|
| Female | 362 | 2024 | 380200 | 0.950 |
Why?
|
| Genetic Association Studies | 18 | 2023 | 2703 | 0.920 |
Why?
|
| Cachexia | 3 | 2020 | 205 | 0.890 |
Why?
|
| Genetic Variation | 32 | 2022 | 6542 | 0.860 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2021 | 3 | 0.840 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 5 | 2008 | 42 | 0.830 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2021 | 17 | 0.830 |
Why?
|
| Pulmonary Artery | 8 | 2021 | 1912 | 0.810 |
Why?
|
| Computational Biology | 12 | 2023 | 3519 | 0.810 |
Why?
|
| Amyloid beta-Protein Precursor | 7 | 2010 | 1121 | 0.810 |
Why?
|
| Membrane Glycoproteins | 13 | 2021 | 3771 | 0.790 |
Why?
|
| Lupus Erythematosus, Systemic | 16 | 2013 | 2104 | 0.780 |
Why?
|
| Linkage Disequilibrium | 29 | 2021 | 1997 | 0.760 |
Why?
|
| Receptors, Cell Surface | 12 | 2010 | 2866 | 0.740 |
Why?
|
| Carrier Proteins | 13 | 2021 | 5023 | 0.730 |
Why?
|
| Genetic Markers | 18 | 2022 | 2634 | 0.690 |
Why?
|
| Gene Regulatory Networks | 12 | 2024 | 1708 | 0.690 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2019 | 56 | 0.690 |
Why?
|
| Haplotypes | 24 | 2021 | 2779 | 0.680 |
Why?
|
| Lung Diseases | 9 | 2023 | 1887 | 0.670 |
Why?
|
| Risk Factors | 96 | 2023 | 72295 | 0.650 |
Why?
|
| DNA | 11 | 2020 | 7294 | 0.630 |
Why?
|
| Quantitative Trait Loci | 19 | 2021 | 2019 | 0.630 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 5 | 2018 | 49 | 0.630 |
Why?
|
| Dyspnea | 12 | 2024 | 1303 | 0.630 |
Why?
|
| Glutathione S-Transferase pi | 3 | 2016 | 97 | 0.630 |
Why?
|
| Longitudinal Studies | 47 | 2023 | 13988 | 0.630 |
Why?
|
| Heterozygote | 13 | 2022 | 2804 | 0.620 |
Why?
|
| Immunoglobulin E | 18 | 2021 | 1463 | 0.620 |
Why?
|
| Bronchiectasis | 4 | 2023 | 128 | 0.620 |
Why?
|
| Genomics | 17 | 2024 | 5717 | 0.610 |
Why?
|
| Body Mass Index | 14 | 2022 | 12720 | 0.600 |
Why?
|
| Albuterol | 6 | 2014 | 208 | 0.600 |
Why?
|
| Systems Biology | 4 | 2020 | 469 | 0.590 |
Why?
|
| Social Work | 1 | 2018 | 162 | 0.590 |
Why?
|
| Serpin E2 | 8 | 2020 | 48 | 0.580 |
Why?
|
| Gene Expression | 13 | 2020 | 7798 | 0.560 |
Why?
|
| Respiration | 2 | 2017 | 1653 | 0.560 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 164 | 0.550 |
Why?
|
| Pedigree | 19 | 2017 | 4642 | 0.550 |
Why?
|
| Gene Frequency | 31 | 2022 | 3587 | 0.550 |
Why?
|
| Cohort Studies | 76 | 2023 | 40558 | 0.550 |
Why?
|
| Desmoplakins | 4 | 2022 | 62 | 0.530 |
Why?
|
| Databases, Genetic | 6 | 2019 | 1783 | 0.530 |
Why?
|
| Maximal Midexpiratory Flow Rate | 3 | 2004 | 78 | 0.520 |
Why?
|
| Proteomics | 7 | 2024 | 3638 | 0.500 |
Why?
|
| Models, Organizational | 1 | 2018 | 574 | 0.500 |
Why?
|
| Aged, 80 and over | 73 | 2022 | 57776 | 0.500 |
Why?
|
| Adult | 135 | 2023 | 214056 | 0.490 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 2204 | 0.490 |
Why?
|
| Alleles | 23 | 2023 | 6933 | 0.480 |
Why?
|
| Rare Diseases | 1 | 2019 | 553 | 0.480 |
Why?
|
| Airway Obstruction | 5 | 2024 | 664 | 0.470 |
Why?
|
| Empathy | 1 | 2018 | 474 | 0.470 |
Why?
|
| Exercise Tolerance | 10 | 2015 | 768 | 0.470 |
Why?
|
| Bronchi | 5 | 2022 | 840 | 0.460 |
Why?
|
| Protease Nexins | 7 | 2010 | 40 | 0.450 |
Why?
|
| Age of Onset | 15 | 2018 | 3270 | 0.440 |
Why?
|
| Gene Expression Regulation | 18 | 2024 | 12073 | 0.440 |
Why?
|
| Total Lung Capacity | 8 | 2020 | 143 | 0.440 |
Why?
|
| DNA Methylation | 10 | 2022 | 4287 | 0.440 |
Why?
|
| Elastin | 3 | 2010 | 308 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 14 | 2023 | 5868 | 0.430 |
Why?
|
| Proteome | 2 | 2021 | 1798 | 0.420 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 7 | 2022 | 314 | 0.420 |
Why?
|
| Risk Assessment | 23 | 2022 | 23336 | 0.420 |
Why?
|
| Genome | 5 | 2024 | 1807 | 0.410 |
Why?
|
| Disease | 2 | 2020 | 680 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2019 | 460 | 0.410 |
Why?
|
| Gene Expression Profiling | 16 | 2024 | 9445 | 0.400 |
Why?
|
| Cluster Analysis | 13 | 2023 | 2715 | 0.400 |
Why?
|
| Computer Simulation | 20 | 2022 | 6194 | 0.400 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2011 | 179 | 0.390 |
Why?
|
| Chromosome Mapping | 14 | 2015 | 4740 | 0.390 |
Why?
|
| Information Services | 1 | 2012 | 244 | 0.390 |
Why?
|
| Respiratory System Abnormalities | 2 | 2022 | 69 | 0.390 |
Why?
|
| Inflammation | 11 | 2023 | 10636 | 0.390 |
Why?
|
| Epithelial Cells | 5 | 2020 | 3690 | 0.380 |
Why?
|
| Tobacco Smoke Pollution | 7 | 2013 | 816 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 9 | 2021 | 4464 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 4 | 7 | 2019 | 374 | 0.380 |
Why?
|
| Family | 14 | 2017 | 3147 | 0.370 |
Why?
|
| Receptors, Adrenergic, beta-2 | 5 | 2004 | 201 | 0.370 |
Why?
|
| Community Networks | 1 | 2012 | 203 | 0.370 |
Why?
|
| Logistic Models | 27 | 2021 | 13409 | 0.370 |
Why?
|
| Mucin-5B | 6 | 2023 | 141 | 0.370 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 213 | 0.360 |
Why?
|
| Consensus | 1 | 2019 | 2960 | 0.360 |
Why?
|
| beta-Defensins | 2 | 2006 | 57 | 0.350 |
Why?
|
| Pulmonary Fibrosis | 6 | 2021 | 530 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2006 | 462 | 0.350 |
Why?
|
| Airway Resistance | 2 | 2013 | 404 | 0.350 |
Why?
|
| Genetic Techniques | 1 | 2012 | 435 | 0.340 |
Why?
|
| Predictive Value of Tests | 21 | 2022 | 15078 | 0.340 |
Why?
|
| Tandem Repeat Sequences | 3 | 2005 | 185 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 326 | 0.340 |
Why?
|
| Norway | 9 | 2015 | 448 | 0.330 |
Why?
|
| Algorithms | 21 | 2024 | 13882 | 0.330 |
Why?
|
| Sputum | 5 | 2023 | 476 | 0.330 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 990 | 0.330 |
Why?
|
| Epigenomics | 5 | 2021 | 903 | 0.320 |
Why?
|
| Quality of Life | 22 | 2023 | 12803 | 0.320 |
Why?
|
| Williams Syndrome | 1 | 2010 | 187 | 0.310 |
Why?
|
| Exons | 8 | 2023 | 2439 | 0.310 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2011 | 88 | 0.310 |
Why?
|
| Interleukin-10 | 5 | 2009 | 1200 | 0.300 |
Why?
|
| Software | 11 | 2020 | 4442 | 0.300 |
Why?
|
| Follow-Up Studies | 33 | 2023 | 39052 | 0.300 |
Why?
|
| Macrophages, Alveolar | 2 | 2020 | 407 | 0.300 |
Why?
|
| Sex Characteristics | 6 | 2014 | 2585 | 0.300 |
Why?
|
| Germ-Line Mutation | 4 | 2023 | 1788 | 0.290 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 54 | 0.290 |
Why?
|
| Respiratory Physiological Phenomena | 4 | 2023 | 188 | 0.280 |
Why?
|
| Republic of Korea | 5 | 2022 | 538 | 0.280 |
Why?
|
| Serpins | 2 | 2015 | 247 | 0.280 |
Why?
|
| DNA Helicases | 2 | 2019 | 861 | 0.280 |
Why?
|
| Radiography, Thoracic | 8 | 2015 | 1265 | 0.280 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2014 | 1341 | 0.270 |
Why?
|
| Bronchitis | 4 | 2017 | 200 | 0.270 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 6 | 2010 | 1184 | 0.270 |
Why?
|
| Pectoralis Muscles | 2 | 2018 | 82 | 0.270 |
Why?
|
| Chemokines, CC | 3 | 2014 | 291 | 0.260 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2006 | 544 | 0.260 |
Why?
|
| Cross-Sectional Studies | 33 | 2024 | 25041 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2015 | 403 | 0.260 |
Why?
|
| Lupus Erythematosus, Cutaneous | 2 | 2010 | 58 | 0.260 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4232 | 0.260 |
Why?
|
| Multivariate Analysis | 20 | 2019 | 12244 | 0.260 |
Why?
|
| Comorbidity | 16 | 2022 | 10388 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 5 | 2022 | 2012 | 0.260 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2019 | 536 | 0.260 |
Why?
|
| RNA, Untranslated | 2 | 2020 | 453 | 0.260 |
Why?
|
| Prospective Studies | 31 | 2024 | 53291 | 0.260 |
Why?
|
| Curriculum | 1 | 2018 | 3605 | 0.260 |
Why?
|
| Dermatitis, Atopic | 3 | 2021 | 654 | 0.260 |
Why?
|
| Poland | 2 | 2017 | 184 | 0.250 |
Why?
|
| Pneumonectomy | 3 | 2009 | 1094 | 0.250 |
Why?
|
| Lod Score | 6 | 2009 | 614 | 0.250 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2019 | 644 | 0.250 |
Why?
|
| Pulmonary Ventilation | 4 | 2013 | 374 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 7 | 2019 | 4805 | 0.250 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 582 | 0.250 |
Why?
|
| Respiratory Mechanics | 4 | 2013 | 686 | 0.250 |
Why?
|
| Child | 65 | 2023 | 77708 | 0.250 |
Why?
|
| Heart Block | 2 | 2000 | 410 | 0.250 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2022 | 810 | 0.240 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.240 |
Why?
|
| Lymphangioleiomyomatosis | 2 | 2019 | 210 | 0.240 |
Why?
|
| United States | 45 | 2022 | 69869 | 0.240 |
Why?
|
| Prognosis | 26 | 2023 | 29060 | 0.240 |
Why?
|
| Prevalence | 18 | 2023 | 15221 | 0.240 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 18034 | 0.230 |
Why?
|
| Medicine | 1 | 2012 | 946 | 0.230 |
Why?
|
| Sex Factors | 13 | 2021 | 10400 | 0.230 |
Why?
|
| Linear Models | 14 | 2024 | 5952 | 0.230 |
Why?
|
| Family Health | 7 | 2009 | 1281 | 0.230 |
Why?
|
| Genetic Testing | 7 | 2021 | 3444 | 0.220 |
Why?
|
| Respiratory Mucosa | 2 | 2019 | 427 | 0.220 |
Why?
|
| Reproducibility of Results | 19 | 2024 | 19905 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 2007 | 0.220 |
Why?
|
| Uteroglobin | 3 | 2012 | 58 | 0.220 |
Why?
|
| Nuclear Family | 5 | 2011 | 318 | 0.210 |
Why?
|
| Nedocromil | 2 | 2019 | 46 | 0.210 |
Why?
|
| Transplantation Chimera | 1 | 2005 | 613 | 0.210 |
Why?
|
| RNA Splice Sites | 1 | 2023 | 209 | 0.210 |
Why?
|
| Models, Statistical | 8 | 2021 | 5101 | 0.210 |
Why?
|
| Hypertension, Pulmonary | 3 | 2015 | 1534 | 0.210 |
Why?
|
| Regression Analysis | 11 | 2022 | 6459 | 0.210 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 468 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 3596 | 0.210 |
Why?
|
| Somatomedins | 1 | 2022 | 192 | 0.210 |
Why?
|
| Internationality | 4 | 2020 | 1002 | 0.210 |
Why?
|
| Odds Ratio | 11 | 2022 | 9849 | 0.210 |
Why?
|
| Bronchography | 2 | 2013 | 74 | 0.210 |
Why?
|
| Respiratory System | 4 | 2016 | 557 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.210 |
Why?
|
| Chromosomes, Human | 2 | 2013 | 457 | 0.200 |
Why?
|
| Leukocytes | 2 | 2021 | 2045 | 0.200 |
Why?
|
| Activin Receptors, Type I | 2 | 2019 | 142 | 0.200 |
Why?
|
| Environment | 4 | 2019 | 1123 | 0.200 |
Why?
|
| Budesonide | 2 | 2019 | 154 | 0.200 |
Why?
|
| Animals | 39 | 2023 | 168770 | 0.200 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 213 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 8 | 2021 | 2716 | 0.190 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 187 | 0.190 |
Why?
|
| Protein Interaction Mapping | 2 | 2023 | 627 | 0.190 |
Why?
|
| ADAM Proteins | 3 | 2020 | 243 | 0.190 |
Why?
|
| Memory Disorders | 1 | 2008 | 1186 | 0.190 |
Why?
|
| Mosaicism | 1 | 2023 | 441 | 0.190 |
Why?
|
| Acetyltransferases | 1 | 2021 | 234 | 0.190 |
Why?
|
| Bayes Theorem | 6 | 2021 | 2308 | 0.180 |
Why?
|
| Polycythemia | 1 | 2021 | 126 | 0.180 |
Why?
|
| Mucus | 3 | 2023 | 321 | 0.180 |
Why?
|
| Cause of Death | 4 | 2020 | 3582 | 0.180 |
Why?
|
| Lymphocytes | 2 | 2021 | 2617 | 0.180 |
Why?
|
| Mucins | 1 | 2023 | 564 | 0.180 |
Why?
|
| Response Elements | 1 | 2021 | 312 | 0.180 |
Why?
|
| C-Reactive Protein | 6 | 2012 | 3778 | 0.180 |
Why?
|
| Genetics, Population | 5 | 2019 | 934 | 0.180 |
Why?
|
| Chromatin | 2 | 2021 | 2934 | 0.180 |
Why?
|
| COUP Transcription Factor II | 1 | 2019 | 18 | 0.170 |
Why?
|
| Hyperostosis | 1 | 2019 | 22 | 0.170 |
Why?
|
| Tomography, Emission-Computed | 1 | 2022 | 1144 | 0.170 |
Why?
|
| Birds | 1 | 2000 | 163 | 0.170 |
Why?
|
| Airway Remodeling | 6 | 2017 | 132 | 0.170 |
Why?
|
| Models, Biological | 6 | 2017 | 9584 | 0.170 |
Why?
|
| Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2019 | 24 | 0.170 |
Why?
|
| beta-Globins | 1 | 2019 | 115 | 0.170 |
Why?
|
| Women | 1 | 2001 | 230 | 0.170 |
Why?
|
| Haemophilus influenzae | 1 | 2019 | 172 | 0.170 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2007 | 337 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2020 | 380 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 3 | 2013 | 915 | 0.170 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.170 |
Why?
|
| Bronchoconstriction | 1 | 1999 | 143 | 0.170 |
Why?
|
| Alternative Splicing | 3 | 2023 | 1117 | 0.170 |
Why?
|
| Cell Line | 5 | 2021 | 16000 | 0.170 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 216 | 0.160 |
Why?
|
| Cough | 5 | 2019 | 555 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2023 | 908 | 0.160 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7882 | 0.160 |
Why?
|
| Oxygen | 4 | 2023 | 4189 | 0.160 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 1401 | 0.160 |
Why?
|
| Hospitals, Psychiatric | 1 | 2000 | 332 | 0.160 |
Why?
|
| Heme | 1 | 2020 | 307 | 0.160 |
Why?
|
| Gastroesophageal Reflux | 2 | 2014 | 782 | 0.160 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1998 | 144 | 0.160 |
Why?
|
| Adolescent | 39 | 2021 | 85784 | 0.150 |
Why?
|
| Interleukin-13 | 3 | 2007 | 389 | 0.150 |
Why?
|
| Mice | 21 | 2023 | 81202 | 0.150 |
Why?
|
| Costa Rica | 9 | 2011 | 177 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2019 | 2850 | 0.150 |
Why?
|
| Homozygote | 2 | 2016 | 1787 | 0.150 |
Why?
|
| Fibroblasts | 3 | 2021 | 4162 | 0.150 |
Why?
|
| CpG Islands | 5 | 2021 | 1171 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2019 | 197 | 0.150 |
Why?
|
| Programming Languages | 1 | 2018 | 133 | 0.150 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 182 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 1005 | 0.150 |
Why?
|
| Multifactorial Inheritance | 2 | 2022 | 1194 | 0.150 |
Why?
|
| Mutation | 14 | 2023 | 29786 | 0.150 |
Why?
|
| Chi-Square Distribution | 6 | 2017 | 3508 | 0.150 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2011 | 367 | 0.150 |
Why?
|
| Pharmacogenetics | 4 | 2007 | 674 | 0.150 |
Why?
|
| Leukotrienes | 1 | 1998 | 255 | 0.150 |
Why?
|
| Hemizygote | 1 | 2016 | 28 | 0.150 |
Why?
|
| Exosomes | 1 | 2021 | 417 | 0.150 |
Why?
|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 1996 | 13 | 0.140 |
Why?
|
| Hematopoiesis | 2 | 2023 | 2073 | 0.140 |
Why?
|
| Cognition Disorders | 2 | 2008 | 4043 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 570 | 0.140 |
Why?
|
| Receptors, Immunologic | 3 | 2013 | 1423 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2005 | 1155 | 0.140 |
Why?
|
| Health Status | 7 | 2016 | 4033 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 794 | 0.140 |
Why?
|
| Epigenesis, Genetic | 8 | 2021 | 3647 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2021 | 367 | 0.140 |
Why?
|
| Walking | 6 | 2014 | 1180 | 0.140 |
Why?
|
| Multigene Family | 2 | 2013 | 1102 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2023 | 3751 | 0.140 |
Why?
|
| Eosinophils | 3 | 2018 | 955 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 128 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2015 | 373 | 0.130 |
Why?
|
| Iron-Binding Proteins | 1 | 2016 | 79 | 0.130 |
Why?
|
| Nose | 1 | 2019 | 509 | 0.130 |
Why?
|
| Forecasting | 3 | 2022 | 2951 | 0.130 |
Why?
|
| Mothers | 2 | 2011 | 2165 | 0.130 |
Why?
|
| Protein Transport | 1 | 2021 | 1988 | 0.130 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2017 | 225 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2021 | 967 | 0.130 |
Why?
|
| Placebo Effect | 1 | 2019 | 502 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2016 | 323 | 0.130 |
Why?
|
| Incidence | 14 | 2022 | 20950 | 0.130 |
Why?
|
| Hernia, Hiatal | 1 | 1996 | 79 | 0.130 |
Why?
|
| Models, Psychological | 1 | 2000 | 811 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2016 | 300 | 0.130 |
Why?
|
| Galactosylceramidase | 1 | 2015 | 19 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 638 | 0.130 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2019 | 257 | 0.130 |
Why?
|
| Smoking Cessation | 5 | 2020 | 2071 | 0.130 |
Why?
|
| Klinefelter Syndrome | 1 | 2015 | 48 | 0.130 |
Why?
|
| Population | 1 | 2015 | 142 | 0.130 |
Why?
|
| Hypoprothrombinemias | 1 | 1994 | 2 | 0.130 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2019 | 329 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2000 | 2036 | 0.130 |
Why?
|
| Mexican Americans | 3 | 2004 | 165 | 0.130 |
Why?
|
| Iron Chelating Agents | 1 | 2016 | 139 | 0.130 |
Why?
|
| Young Adult | 15 | 2021 | 56434 | 0.130 |
Why?
|
| Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
| Retrospective Studies | 19 | 2022 | 77459 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2000 | 506 | 0.120 |
Why?
|
| Ovary | 1 | 1999 | 981 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 328 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 5 | 2016 | 1677 | 0.120 |
Why?
|
| Pneumothorax | 2 | 2014 | 379 | 0.120 |
Why?
|
| Smoke | 1 | 2016 | 227 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 44 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2018 | 4042 | 0.120 |
Why?
|
| Boston | 6 | 2020 | 9312 | 0.120 |
Why?
|
| Telomerase | 2 | 2019 | 730 | 0.120 |
Why?
|
| Sensitivity and Specificity | 14 | 2013 | 14723 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1338 | 0.120 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 103 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2012 | 4424 | 0.110 |
Why?
|
| Base Sequence | 9 | 2019 | 12797 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 2213 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2916 | 0.110 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2013 | 33 | 0.110 |
Why?
|
| Manikins | 1 | 2015 | 238 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 3390 | 0.110 |
Why?
|
| Chemokines | 1 | 2017 | 970 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3921 | 0.110 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 57 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2024 | 23406 | 0.110 |
Why?
|
| Blood Cells | 1 | 2015 | 309 | 0.110 |
Why?
|
| Medical History Taking | 1 | 2017 | 784 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 714 | 0.110 |
Why?
|
| Pneumonia | 3 | 2017 | 2133 | 0.110 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2012 | 16 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
| Movement | 1 | 2000 | 1471 | 0.110 |
Why?
|
| Soft Tissue Infections | 1 | 2014 | 155 | 0.110 |
Why?
|
| Hospitalization | 6 | 2014 | 10259 | 0.110 |
Why?
|
| Radiology | 1 | 2007 | 2099 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2016 | 4026 | 0.110 |
Why?
|
| Immunity, Innate | 4 | 2018 | 2962 | 0.110 |
Why?
|
| Traction | 2 | 2023 | 106 | 0.110 |
Why?
|
| Body Composition | 4 | 2017 | 2402 | 0.110 |
Why?
|
| Europe | 3 | 2019 | 3339 | 0.110 |
Why?
|
| DNA-Binding Proteins | 6 | 2020 | 9647 | 0.110 |
Why?
|
| Hepatitis C | 1 | 2023 | 1591 | 0.110 |
Why?
|
| Ankyrins | 1 | 2012 | 128 | 0.110 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1178 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 4 | 2013 | 885 | 0.110 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2012 | 346 | 0.110 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 29 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2005 | 319 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4208 | 0.100 |
Why?
|
| Cadherins | 1 | 2017 | 907 | 0.100 |
Why?
|
| Metalloendopeptidases | 2 | 2004 | 396 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 170 | 0.100 |
Why?
|
| Occupational Exposure | 4 | 2014 | 1793 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 1994 | 165 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 8949 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2752 | 0.100 |
Why?
|
| Lead | 3 | 2007 | 852 | 0.100 |
Why?
|
| Metabolomics | 3 | 2019 | 1485 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2001 | 2052 | 0.100 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 514 | 0.100 |
Why?
|
| Cytokines | 4 | 2017 | 7323 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2000 | 1881 | 0.100 |
Why?
|
| Cells, Cultured | 7 | 2021 | 19233 | 0.100 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2011 | 75 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 61 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2000 | 1218 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2022 | 10252 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 2 | 2014 | 722 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2016 | 1790 | 0.100 |
Why?
|
| Weight Loss | 2 | 2021 | 2625 | 0.100 |
Why?
|
| Liver Diseases | 2 | 2010 | 1253 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2016 | 1124 | 0.100 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 1991 | 21 | 0.100 |
Why?
|
| Clinical Competence | 2 | 2018 | 4687 | 0.100 |
Why?
|
| SOXD Transcription Factors | 1 | 2011 | 47 | 0.100 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2010 | 10 | 0.100 |
Why?
|
| Exercise Test | 3 | 2014 | 2073 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2016 | 368 | 0.100 |
Why?
|
| Administration, Inhalation | 5 | 2016 | 1105 | 0.100 |
Why?
|
| beta Catenin | 1 | 2016 | 1059 | 0.100 |
Why?
|
| Obesity | 4 | 2022 | 12745 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1736 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 2938 | 0.090 |
Why?
|
| Lung Neoplasms | 4 | 2019 | 13104 | 0.090 |
Why?
|
| Superoxide Dismutase | 2 | 2010 | 596 | 0.090 |
Why?
|
| Mortality | 2 | 2019 | 2864 | 0.090 |
Why?
|
| Leukocyte Count | 4 | 2018 | 1588 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 1941 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 528 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1480 | 0.090 |
Why?
|
| Respiratory Sounds | 3 | 2019 | 696 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2441 | 0.090 |
Why?
|
| Aging | 3 | 2021 | 8663 | 0.090 |
Why?
|
| Allergens | 4 | 2007 | 1320 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 2 | 2019 | 1364 | 0.090 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2009 | 49 | 0.090 |
Why?
|
| Sirtuin 2 | 1 | 2010 | 97 | 0.090 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 1741 | 0.090 |
Why?
|
| Mammography | 1 | 2001 | 2475 | 0.090 |
Why?
|
| Microarray Analysis | 3 | 2009 | 767 | 0.090 |
Why?
|
| Research Design | 6 | 2020 | 5986 | 0.090 |
Why?
|
| Densitometry | 1 | 2010 | 156 | 0.090 |
Why?
|
| Cilia | 1 | 2013 | 466 | 0.090 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 343 | 0.090 |
Why?
|
| Tobacco Use Disorder | 2 | 2017 | 688 | 0.090 |
Why?
|
| Microsatellite Repeats | 3 | 2006 | 802 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 1240 | 0.090 |
Why?
|
| Aortic Diseases | 2 | 2010 | 743 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2022 | 1912 | 0.090 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 42 | 0.090 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.090 |
Why?
|
| Radiography | 6 | 2016 | 7023 | 0.090 |
Why?
|
| Health Policy | 2 | 2020 | 2661 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 322 | 0.080 |
Why?
|
| Transcription Factors | 5 | 2022 | 12209 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
| Suicide | 1 | 2000 | 1474 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 1199 | 0.080 |
Why?
|
| Transition Temperature | 1 | 2008 | 36 | 0.080 |
Why?
|
| Leadership | 1 | 2018 | 1357 | 0.080 |
Why?
|
| Mitochondria | 2 | 2016 | 3514 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 320 | 0.080 |
Why?
|
| Siblings | 3 | 2008 | 854 | 0.080 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 78 | 0.080 |
Why?
|
| Iron | 2 | 2016 | 1774 | 0.080 |
Why?
|
| Sick Leave | 1 | 2009 | 110 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 728 | 0.080 |
Why?
|
| RNA | 4 | 2023 | 2749 | 0.080 |
Why?
|
| Penetrance | 2 | 2023 | 381 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 894 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 1828 | 0.080 |
Why?
|
| Trachea | 2 | 2013 | 1076 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2020 | 4222 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2009 | 122 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2115 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 850 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2010 | 393 | 0.080 |
Why?
|
| Educational Status | 2 | 2015 | 2540 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2015 | 1856 | 0.080 |
Why?
|
| Coronary Artery Disease | 3 | 2019 | 6486 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2015 | 696 | 0.080 |
Why?
|
| Statistics as Topic | 5 | 2015 | 2373 | 0.080 |
Why?
|
| Analysis of Variance | 7 | 2014 | 6366 | 0.080 |
Why?
|
| Osteoporosis | 2 | 2015 | 1579 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2000 | 2133 | 0.080 |
Why?
|
| Sample Size | 2 | 2022 | 845 | 0.080 |
Why?
|
| Telomere | 3 | 2022 | 910 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 449 | 0.080 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3280 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 3 | 2014 | 280 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1656 | 0.080 |
Why?
|
| Observer Variation | 3 | 2012 | 2593 | 0.080 |
Why?
|
| Phencyclidine | 1 | 1987 | 61 | 0.080 |
Why?
|
| Infant | 6 | 2021 | 35134 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 687 | 0.080 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 4 | 1999 | 546 | 0.080 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2108 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 6171 | 0.080 |
Why?
|
| Ascaris lumbricoides | 1 | 2007 | 11 | 0.080 |
Why?
|
| Depression | 3 | 2018 | 7766 | 0.080 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 236 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1987 | 178 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 136 | 0.070 |
Why?
|
| Cleft Lip | 1 | 2012 | 478 | 0.070 |
Why?
|
| Fibrinogen | 3 | 2019 | 894 | 0.070 |
Why?
|
| Self Report | 2 | 2018 | 3557 | 0.070 |
Why?
|
| Hypercapnia | 1 | 2008 | 260 | 0.070 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15159 | 0.070 |
Why?
|
| Decision Making | 1 | 2001 | 3888 | 0.070 |
Why?
|
| Quality Control | 2 | 2021 | 841 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2021 | 1264 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 11725 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 495 | 0.070 |
Why?
|
| Cleft Palate | 1 | 2012 | 560 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 612 | 0.070 |
Why?
|
| Age Factors | 9 | 2018 | 18373 | 0.070 |
Why?
|
| North America | 1 | 2010 | 1249 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4479 | 0.070 |
Why?
|
| Child, Preschool | 13 | 2021 | 41005 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3326 | 0.070 |
Why?
|
| Antiparkinson Agents | 1 | 1987 | 184 | 0.070 |
Why?
|
| Disease Susceptibility | 5 | 2017 | 1782 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2010 | 498 | 0.070 |
Why?
|
| Bronchial Provocation Tests | 3 | 2003 | 227 | 0.070 |
Why?
|
| Autoantigens | 1 | 1991 | 892 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.070 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2006 | 42 | 0.070 |
Why?
|
| Interleukin-6 | 3 | 2012 | 3203 | 0.070 |
Why?
|
| Coronary Disease | 2 | 2020 | 6077 | 0.070 |
Why?
|
| Arteriosclerosis | 1 | 2010 | 1092 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2016 | 3873 | 0.070 |
Why?
|
| Estradiol | 1 | 2013 | 2020 | 0.070 |
Why?
|
| Autophagy | 1 | 2013 | 1297 | 0.070 |
Why?
|
| Treatment Outcome | 12 | 2020 | 63115 | 0.070 |
Why?
|
| Patella | 1 | 2007 | 320 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2009 | 836 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 98 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1400 | 0.060 |
Why?
|
| Pancreas | 1 | 1992 | 1687 | 0.060 |
Why?
|
| Glutathione Transferase | 2 | 2009 | 595 | 0.060 |
Why?
|
| Markov Chains | 2 | 2021 | 969 | 0.060 |
Why?
|
| Skin Tests | 5 | 2007 | 613 | 0.060 |
Why?
|
| Pyrroles | 1 | 2012 | 1146 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 1987 | 576 | 0.060 |
Why?
|
| Rest | 3 | 2016 | 901 | 0.060 |
Why?
|
| Learning | 1 | 2015 | 1712 | 0.060 |
Why?
|
| ROC Curve | 3 | 2021 | 3527 | 0.060 |
Why?
|
| Probability | 4 | 2019 | 2506 | 0.060 |
Why?
|
| Japan | 2 | 2021 | 1360 | 0.060 |
Why?
|
| Registries | 3 | 2019 | 8091 | 0.060 |
Why?
|
| Skin Aging | 1 | 2006 | 127 | 0.060 |
Why?
|
| Thinness | 2 | 2022 | 480 | 0.060 |
Why?
|
| Calcinosis | 1 | 2014 | 1499 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7722 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2014 | 1860 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2016 | 1005 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 136 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4216 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2005 | 187 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.060 |
Why?
|
| Anesthesiology | 1 | 2015 | 1060 | 0.060 |
Why?
|
| Aorta | 1 | 2012 | 2062 | 0.060 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 18111 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1420 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 979 | 0.060 |
Why?
|
| Autistic Disorder | 1 | 1994 | 1185 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5857 | 0.060 |
Why?
|
| Fluocinolone Acetonide | 1 | 2004 | 36 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 1999 | 1547 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2918 | 0.060 |
Why?
|
| Time Factors | 8 | 2020 | 40077 | 0.060 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 87 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2011 | 5181 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 272 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 761 | 0.060 |
Why?
|
| Sleep | 1 | 2019 | 4623 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 2 | 2021 | 1343 | 0.060 |
Why?
|
| Agranulocytosis | 1 | 1983 | 101 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 4185 | 0.060 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2005 | 284 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3505 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2023 | 13035 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2024 | 1660 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1703 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 707 | 0.060 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8038 | 0.060 |
Why?
|
| Azathioprine | 2 | 1996 | 354 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 798 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 471 | 0.050 |
Why?
|
| HIV Infections | 2 | 2023 | 16715 | 0.050 |
Why?
|
| Employment | 1 | 2009 | 1132 | 0.050 |
Why?
|
| Hemochromatosis | 1 | 2004 | 184 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2007 | 541 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 4554 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2003 | 2887 | 0.050 |
Why?
|
| Pulmonary Alveoli | 2 | 2017 | 675 | 0.050 |
Why?
|
| Physics | 1 | 2022 | 87 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1222 | 0.050 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1983 | 174 | 0.050 |
Why?
|
| Oximetry | 2 | 2016 | 471 | 0.050 |
Why?
|
| Bone Density | 1 | 2015 | 3468 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 977 | 0.050 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 49 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2004 | 348 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14561 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 580 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5321 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2013 | 170 | 0.050 |
Why?
|
| Neoplasms | 4 | 2021 | 21693 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
| Dust | 2 | 2013 | 482 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1085 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2021 | 127 | 0.050 |
Why?
|
| Tibia | 1 | 2007 | 1077 | 0.050 |
Why?
|
| Pregnancy | 5 | 2023 | 29144 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 2003 | 301 | 0.050 |
Why?
|
| Lymphopenia | 1 | 1983 | 285 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 940 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11486 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 33 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 1366 | 0.050 |
Why?
|
| Myosins | 1 | 2022 | 409 | 0.050 |
Why?
|
| Residual Volume | 2 | 2011 | 41 | 0.050 |
Why?
|
| Polyadenylation | 1 | 2021 | 117 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 1725 | 0.050 |
Why?
|
| Pancreatic Elastase | 2 | 1992 | 136 | 0.050 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 12356 | 0.050 |
Why?
|
| Forced Expiratory Flow Rates | 2 | 2010 | 74 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
| Propensity Score | 2 | 2019 | 1781 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1793 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2003 | 641 | 0.050 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 72 | 0.050 |
Why?
|
| Population Density | 1 | 2021 | 196 | 0.050 |
Why?
|
| TATA Box Binding Protein-Like Proteins | 1 | 2019 | 8 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 21833 | 0.050 |
Why?
|
| Genes, Switch | 1 | 2020 | 47 | 0.050 |
Why?
|
| Chronic Disease | 5 | 2019 | 9145 | 0.050 |
Why?
|
| Species Specificity | 1 | 2004 | 2478 | 0.050 |
Why?
|
| Observation | 2 | 2012 | 312 | 0.050 |
Why?
|
| Bronchospirometry | 2 | 2011 | 10 | 0.050 |
Why?
|
| Pliability | 1 | 2019 | 63 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 5035 | 0.040 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1999 | 24 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 32 | 0.040 |
Why?
|
| beta Karyopherins | 1 | 2019 | 47 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 30 | 0.040 |
Why?
|
| Arylsulfotransferase | 1 | 2019 | 28 | 0.040 |
Why?
|
| rab4 GTP-Binding Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1622 | 0.040 |
Why?
|
| Risk | 3 | 2016 | 9688 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1903 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 125 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 279 | 0.040 |
Why?
|
| Eczema | 1 | 2002 | 231 | 0.040 |
Why?
|
| Steroidogenic Factor 1 | 1 | 1999 | 46 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 222 | 0.040 |
Why?
|
| Air | 1 | 2020 | 182 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2010 | 25628 | 0.040 |
Why?
|
| Interleukin-8 | 2 | 2012 | 690 | 0.040 |
Why?
|
| Leukotriene Antagonists | 1 | 2000 | 127 | 0.040 |
Why?
|
| Salicylates | 2 | 1991 | 126 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2021 | 338 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2000 | 379 | 0.040 |
Why?
|
| X Chromosome | 1 | 2023 | 814 | 0.040 |
Why?
|
| Hypersensitivity | 2 | 2012 | 1102 | 0.040 |
Why?
|
| Exoribonucleases | 1 | 2019 | 95 | 0.040 |
Why?
|
| England | 1 | 2020 | 522 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 587 | 0.040 |
Why?
|
| Granulosa Cells | 1 | 1999 | 121 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2003 | 591 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2000 | 344 | 0.040 |
Why?
|
| Organ Size | 2 | 2016 | 2251 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 2 | 1991 | 326 | 0.040 |
Why?
|
| Prednisone | 3 | 2012 | 1574 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3338 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1999 | 144 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2002 | 772 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 116 | 0.040 |
Why?
|
| Polymyositis | 1 | 1999 | 75 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1998 | 69 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 672 | 0.040 |
Why?
|
| GATA4 Transcription Factor | 1 | 1999 | 131 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2000 | 234 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2019 | 2971 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 33 | 0.040 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10183 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 6539 | 0.040 |
Why?
|
| Tidal Volume | 2 | 2011 | 490 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2021 | 531 | 0.040 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1998 | 58 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2007 | 1178 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 2007 | 1179 | 0.040 |
Why?
|
| Massachusetts | 2 | 2009 | 8662 | 0.040 |
Why?
|
| Neutropenia | 1 | 1983 | 895 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 286 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11366 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2014 | 2297 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1438 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 1041 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 743 | 0.040 |
Why?
|
| Iceland | 1 | 2017 | 183 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2000 | 264 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 631 | 0.040 |
Why?
|
| Lipoxygenase | 1 | 1997 | 74 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2017 | 73 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10484 | 0.040 |
Why?
|
| Takayasu Arteritis | 1 | 1998 | 96 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1270 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1999 | 744 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2023 | 878 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3255 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2021 | 1730 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 199 | 0.030 |
Why?
|
| Harm Reduction | 1 | 2017 | 129 | 0.030 |
Why?
|
| Oocytes | 1 | 2021 | 1188 | 0.030 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2016 | 195 | 0.030 |
Why?
|
| Canada | 2 | 2013 | 2065 | 0.030 |
Why?
|
| Netherlands | 2 | 2016 | 2170 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 560 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5749 | 0.030 |
Why?
|
| Double-Blind Method | 5 | 2012 | 12025 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 67 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 954 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1147 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 7914 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 189 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3084 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 1081 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3444 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 1084 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7281 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2023 | 1379 | 0.030 |
Why?
|
| Genes | 1 | 1999 | 1893 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6100 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
| Anthropometry | 1 | 2020 | 1350 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2016 | 1526 | 0.030 |
Why?
|
| Aortography | 2 | 2012 | 437 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 6994 | 0.030 |
Why?
|
| Iron, Dietary | 1 | 2016 | 141 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 4320 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2016 | 271 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1211 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2000 | 1254 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 296 | 0.030 |
Why?
|
| Methicillin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Rhinitis | 1 | 2002 | 691 | 0.030 |
Why?
|
| snRNP Core Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 556 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 2014 | 20 | 0.030 |
Why?
|
| DNA Replication | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Mannosidases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5789 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 871 | 0.030 |
Why?
|
| Antioxidants | 1 | 2002 | 1659 | 0.030 |
Why?
|
| Acute Disease | 3 | 2014 | 7147 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 224 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2901 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2006 | 769 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 112 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1070 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1997 | 453 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2539 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2016 | 367 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 1418 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 635 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 2013 | 19 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1994 | 59 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2804 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 712 | 0.030 |
Why?
|
| Methacholine Chloride | 2 | 2006 | 233 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 592 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 590 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2566 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 1213 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2017 | 729 | 0.030 |
Why?
|
| Education | 2 | 2012 | 543 | 0.030 |
Why?
|
| Texas | 1 | 2014 | 391 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 465 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 20823 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 1679 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 69 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 2014 | 86 | 0.030 |
Why?
|
| Inhalation | 1 | 2013 | 143 | 0.030 |
Why?
|
| Adiponectin | 1 | 2019 | 1101 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 417 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 906 | 0.030 |
Why?
|
| Scleroderma, Localized | 1 | 1994 | 79 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2014 | 142 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2001 | 1425 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 847 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1025 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
| Exhalation | 1 | 2013 | 167 | 0.030 |
Why?
|
| Cyclophosphamide | 2 | 1996 | 2242 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2013 | 140 | 0.030 |
Why?
|
| Recurrence | 2 | 2016 | 8340 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 171 | 0.030 |
Why?
|
| Heart Failure | 1 | 2016 | 10895 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 895 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 3001 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Fibrinopeptide A | 1 | 1992 | 44 | 0.030 |
Why?
|
| Trypsinogen | 1 | 1992 | 86 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1683 | 0.030 |
Why?
|
| Scopolamine Derivatives | 1 | 2012 | 23 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Mites | 2 | 2002 | 43 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1525 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Thromboembolism | 1 | 1998 | 987 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 534 | 0.030 |
Why?
|
| Theophylline | 1 | 2012 | 132 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 299 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 287 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 392 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2000 | 2132 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 1973 | 471 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 963 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2003 | 212 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2014 | 370 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2173 | 0.020 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1990 | 44 | 0.020 |
Why?
|
| Body Weight | 2 | 2013 | 4671 | 0.020 |
Why?
|
| Asia | 1 | 2013 | 609 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2004 | 246 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2012 | 139 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 601 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 2126 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 472 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 1994 | 383 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 224 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 1994 | 387 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1591 | 0.020 |
Why?
|
| Cystitis | 1 | 1991 | 93 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2371 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 379 | 0.020 |
Why?
|
| Lung Injury | 1 | 2016 | 436 | 0.020 |
Why?
|
| Bronchioles | 1 | 2010 | 25 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 512 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 689 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1837 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5077 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 465 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2011 | 378 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 901 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6111 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 280 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6038 | 0.020 |
Why?
|
| Rats | 2 | 2013 | 24252 | 0.020 |
Why?
|
| Syndrome | 1 | 1996 | 3252 | 0.020 |
Why?
|
| Prednisolone | 1 | 2011 | 334 | 0.020 |
Why?
|
| Missouri | 1 | 1989 | 117 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1970 | 0.020 |
Why?
|
| Methotrexate | 1 | 1996 | 1728 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 2418 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10943 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 768 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1991 | 202 | 0.020 |
Why?
|
| Phantoms, Imaging | 2 | 2009 | 2480 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2017 | 2968 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1994 | 1663 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1973 | 547 | 0.020 |
Why?
|
| Emotions | 1 | 2001 | 2658 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 1991 | 253 | 0.020 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1989 | 118 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2002 | 593 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 1012 | 0.020 |
Why?
|
| Arthritis | 1 | 1994 | 659 | 0.020 |
Why?
|
| Online Systems | 1 | 2009 | 184 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 1994 | 658 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 339 | 0.020 |
Why?
|
| Cathepsins | 1 | 1989 | 241 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2009 | 264 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 1996 | 961 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2024 | 7730 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2700 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1994 | 1470 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.020 |
Why?
|
| Health Services | 1 | 2013 | 758 | 0.020 |
Why?
|
| Receptors, Phencyclidine | 1 | 1987 | 13 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2560 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1157 | 0.020 |
Why?
|
| tau Proteins | 1 | 2018 | 1868 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8300 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1768 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1991 | 381 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 2599 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 738 | 0.020 |
Why?
|
| Vehicle Emissions | 1 | 2013 | 665 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 2717 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1991 | 675 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1375 | 0.020 |
Why?
|
| Metagenomics | 1 | 2011 | 428 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1797 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2505 | 0.020 |
Why?
|
| Blood Donors | 1 | 1989 | 355 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3706 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 640 | 0.020 |
Why?
|
| Sweden | 1 | 2010 | 1346 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1335 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1151 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 1987 | 231 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 974 | 0.020 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5660 | 0.020 |
Why?
|
| Breath Tests | 1 | 2008 | 280 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2000 | 3748 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4386 | 0.020 |
Why?
|
| Outpatients | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2006 | 133 | 0.020 |
Why?
|
| Korea | 1 | 2006 | 99 | 0.020 |
Why?
|
| Neutrophils | 2 | 2017 | 3721 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 934 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2010 | 435 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 2838 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 1999 | 2958 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2006 | 129 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 638 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4925 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1987 | 1157 | 0.020 |
Why?
|
| Cell Division | 1 | 1994 | 4569 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 2499 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1991 | 1402 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1676 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1359 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 7475 | 0.020 |
Why?
|
| Tropoelastin | 1 | 2005 | 29 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Arthralgia | 1 | 2009 | 456 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3508 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3556 | 0.020 |
Why?
|
| Fibromyalgia | 1 | 2009 | 388 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Health Surveys | 1 | 2015 | 4036 | 0.020 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2004 | 28 | 0.020 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 55 | 0.020 |
Why?
|
| Quebec | 1 | 2004 | 134 | 0.020 |
Why?
|
| Biometry | 1 | 2007 | 558 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2005 | 9957 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1990 | 2184 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2012 | 3914 | 0.010 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 1983 | 14 | 0.010 |
Why?
|
| Body Burden | 1 | 2004 | 158 | 0.010 |
Why?
|
| Puerto Rico | 1 | 2004 | 356 | 0.010 |
Why?
|
| Hypertension | 2 | 2014 | 8479 | 0.010 |
Why?
|
| Apolipoprotein E3 | 1 | 2003 | 97 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 2003 | 127 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1994 | 5524 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2453 | 0.010 |
Why?
|
| Mexico | 1 | 2004 | 689 | 0.010 |
Why?
|
| Air Pollution | 1 | 1996 | 2286 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16692 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2726 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 340 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1531 | 0.010 |
Why?
|
| Pollen | 1 | 2002 | 75 | 0.010 |
Why?
|
| Alternaria | 1 | 2002 | 44 | 0.010 |
Why?
|
| Immune Sera | 2 | 1992 | 641 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cockroaches | 1 | 2002 | 96 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 513 | 0.010 |
Why?
|
| Glucose | 1 | 1994 | 4398 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 658 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2919 | 0.010 |
Why?
|
| Vasculitis | 2 | 1999 | 519 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1996 | 4600 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 992 | 0.010 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2001 | 141 | 0.010 |
Why?
|
| Skin | 1 | 2014 | 4371 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 2000 | 30 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3307 | 0.010 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2000 | 23 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1994 | 4666 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 527 | 0.010 |
Why?
|
| Face | 1 | 2006 | 994 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2013 | 2789 | 0.010 |
Why?
|
| Monocytes | 1 | 1989 | 2596 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 4561 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3922 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2003 | 668 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 565 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 1998 | 12961 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3144 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2010 | 3743 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 302 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 315 | 0.010 |
Why?
|
| Child Welfare | 1 | 2002 | 523 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3589 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1997 | 76 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1997 | 52 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1997 | 138 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 335 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4982 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2003 | 1318 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 1999 | 226 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2010 | 2816 | 0.010 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 281 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5390 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 7785 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4933 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8319 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1998 | 646 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 780 | 0.010 |
Why?
|
| China | 1 | 2000 | 2245 | 0.010 |
Why?
|
| Melanoma | 1 | 1973 | 5511 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 653 | 0.010 |
Why?
|
| Leg Length Inequality | 1 | 1994 | 55 | 0.010 |
Why?
|
| Mass Screening | 1 | 1989 | 5255 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13814 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1973 | 329 | 0.010 |
Why?
|
| Carboxypeptidases A | 1 | 1992 | 49 | 0.010 |
Why?
|
| DNA Primers | 1 | 1997 | 2891 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9274 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 7937 | 0.010 |
Why?
|
| Fever | 2 | 1991 | 1616 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1586 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1998 | 1084 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1992 | 176 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2308 | 0.010 |
Why?
|
| Leukocyte Elastase | 1 | 1992 | 113 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1991 | 57 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2408 | 0.010 |
Why?
|
| Cyanosis | 1 | 1991 | 83 | 0.010 |
Why?
|
| Thrombocytosis | 1 | 1991 | 81 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1994 | 1150 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1999 | 2765 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1994 | 995 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 4777 | 0.010 |
Why?
|
| Cathepsin G | 1 | 1989 | 32 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13695 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1991 | 577 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1989 | 287 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1994 | 879 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1997 | 884 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1572 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1988 | 380 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1989 | 595 | 0.000 |
Why?
|
| Biological Availability | 1 | 1988 | 397 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1973 | 1607 | 0.000 |
Why?
|
| Rabbits | 1 | 1973 | 4894 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1989 | 1799 | 0.000 |
Why?
|
| Stents | 1 | 1998 | 3282 | 0.000 |
Why?
|
| Fibronectins | 1 | 1989 | 726 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 26386 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1989 | 1073 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 1257 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1973 | 1378 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1973 | 4851 | 0.000 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1994 | 2428 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1994 | 6254 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1991 | 3107 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 6582 | 0.000 |
Why?
|
| Protein Binding | 1 | 1991 | 9384 | 0.000 |
Why?
|
| Kidney | 1 | 1988 | 7184 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 35424 | 0.000 |
Why?
|